Titan Pharmaceuticals appoints director Brynner Chiam as acting CEO and CFO

TITAN PHARMACEUTICALS INC

Brynner Chiam appointed acting principal executive officer and principal financial officer effective November 6, 2024.
Company has launched a search for a full-time CEO; Chiam receives no additional compensation.
Chiam is Tax Director at Black Chamber Management with over 20 years of tax consulting experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Brynner Chiam

acting principal executive officer and acting principal financial officer

TITAN PHARMACEUTICALS INC

Effective: 2024-11-06
Filed: November 8, 2024, 6:59 PM ET

On November 6, 2024, the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) appointed Brynner Chiam, a director of the Company, as acting principal executive officer and acting principal financial officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brynner Chiam was appointed as acting principal executive officer and acting principal financial officer at TITAN PHARMACEUTICALS INC.

Action: appointed
Role: acting principal executive officer and acting principal financial officer

Exact text from the filing

On November 6, 2024, the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) appointed Brynner Chiam, a director of the Company, as acting principal executive officer and acting principal financial officer of the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001829126-24-007372

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.